RD
Rajesh Devraj
President & CEO of Rectify Pharmaceuticals
Cambridge, Massachusetts
Overview
Rajesh Devraj is the President & CEO of Rectify Pharma and a Venture Partner at Atlas Venture in Cambridge, Massachusetts. With a strong background in drug discovery and development, he has held leadership roles in various pharmaceutical companies and has successfully led fundraising efforts for Rectify Pharmaceuticals as well as contributed to the growth and development of several biotechnology firms throughout his career.
Work Experience
Venture Partner
2020 - Current
Entrepreneur in Residence
2015 - 2020
Advisor
2013 - 2015
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
President & CEO
2021
Board Director
2015
President and Chief Executive Officer
2013 - 2014
Chief Scientific Officer and Co-founder
2016 - 2020
Through successful sale to Eli Lilly and Company
Board Member
2017 - 2020
Chairman of the Board of Managers
2013 - 2016
Chief Scientific Officer
2015 - 2016
Through successful sale to Bristol-Myers Squibb
Scientific Advisory Board
2012 - 2014
Senior Vice-President
2011 - 2012
Strategic Planning & Business Development
Deciphera Pharmaceuticals focuses on improving kinase inhibitor treatments.
Raised $1,011,500,000.00 from Viking Global Investors, Sphera Global Healthcare Fund, Redmile Group and New Leaf Venture Partners.
Senior Vice-President, Scientific & Portfolio Strategy
2010 - 2011
Vice-President, Portfolio and Medicinal Chemistry
2010 - 2010
Senior Director
2004 - 2010
Director
2003 - 2004
Associate Director & Science Research Fellow
2002 - 2003
Senior Research Advisor and Section Head
2000 - 2002
Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.
Raised $32,000,000,000.00 from Starboard Value.